Floatz logo

Rocuronium

Chronic Postoperative Pain

Medical University of LublinN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Chronic Postoperative Pain cohort.

Asset / SponsorPhaseRating
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Imperial College Healthcare NHS Trust
Phase 4BB
Bxcl501
Zhongda Hospital
Phase 4BB
Oxycodone
Medical University of Silesia
Phase 4BB
Buprenorphine
Medical University of Silesia
Phase 4BB
Pregabalin
Unity Health Toronto
Phase 4BB

View all 16 →

Same molecule, other indications

Rocuronium is also rated in:

Surgical ConditionsDormant
BBB
Indicative ·
73 / 100
View asset →
uterine corpus leiomyomaDormant
BB
Indicative ·
69 / 100
View asset →
intestinal obstructionDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →